U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7662176621Bone Accrual and Hormones in Response to LactationActive, not recruitingNo Results AvailableLactationhttps://ClinicalTrials.gov/show/NCT01563094
7662276622Safety Study of Levocetirizine Oral Solution for Japanese PediatricsCompletedHas ResultsRhinitisDrug: Levocetirizine|Drug: Levocetirizinehttps://ClinicalTrials.gov/show/NCT01563081
7662376623To Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Calcipotriene 0.005%, Applied Under Maximal Use Conditions in 12-16 Year Olds With Plaque PsoriasisRecruitingNo Results AvailablePsoriasisDrug: calcipotrienehttps://ClinicalTrials.gov/show/NCT01563068
7662476624A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic LeukemiaCompletedHas ResultsLeukaemia, Lymphocytic, ChronicDrug: chlorambucil, tablets|Drug: ofatumumab (GSK1841157) infusionhttps://ClinicalTrials.gov/show/NCT01563055
7662576625A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male VolunteersCompletedNo Results AvailableAsthmaDrug: Intravenous (IV) single dose|Drug: Subcutaneous (SC) single dosehttps://ClinicalTrials.gov/show/NCT01563042
7662676626A Dose-ranging Study of Fluticasone Furoate (FF)CompletedHas ResultsAsthmaDrug: Fluticasone Furoate|Drug: Fluticasone Propionate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01563029
7662776627Glucose as a Mediator of Self-control Performances in Patients With SchizophreniaNot yet recruitingNo Results AvailableSchizophreniaDietary Supplement: glucose drinkhttps://ClinicalTrials.gov/show/NCT01563016
7662876628Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With AutismCompletedHas ResultsAutism|Asperger's Syndrome|Pervasive Developmental Disorder Not Otherwise Specified|Generalized Anxiety Disorder|Social Phobia|Separation Anxiety Disorder|Obsessive-compulsive DisorderOther: Cognitive Behavioral Therapy|Other: Treatment as usualhttps://ClinicalTrials.gov/show/NCT01563003
7662976629Phase Ib/II Study of the Efficacy and Safety of the R-CMC544/R-GEMOX Combination in Diffuse Lage B-cell Lymphoma at First or Second RelapseActive, not recruitingNo Results AvailableDiffuse Large B-Cell LymphomaDrug: Rituximab, CMC544, Gemcitabine and Oxaliplatinehttps://ClinicalTrials.gov/show/NCT01562990
7663076630Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCLRecruitingNo Results AvailableAggressive Lymphoma|Diffuse Large B-cell Lymphoma|Mantle Cell LymphomaDrug: Rituximab, Gemcitabine, Oxaliplatin, Dexametasonehttps://ClinicalTrials.gov/show/NCT01562977
7663176631Hypnotherapy in Patients With Chest Pain & Unobstructed CoronariesWithdrawnNo Results AvailableChest Pain|Unobstructed Coronary ArteriesBehavioral: Hypnotherapy|Behavioral: Supportive therapyhttps://ClinicalTrials.gov/show/NCT01562964
7663276632Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With ImmunosuppressantsTerminatedNo Results AvailableCrohn's Disease|Mucosal InflammationDrug: ADALIMUMAB|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01562951
7663376633MEDI-557 Adult DosingCompletedNo Results AvailableRespiratory Syncytial VirusDrug: Placebo|Drug: MEDI-557|Drug: MEDI-557https://ClinicalTrials.gov/show/NCT01562938
7663476634Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney InjuryCompletedNo Results AvailableChronic Renal Failure/ Kidney Disease|Contrast-medium Induced Acute Kidney InjuryDietary Supplement: Red wine|Dietary Supplement: White wine|Dietary Supplement: Beerhttps://ClinicalTrials.gov/show/NCT01562925
7663576635Efficiency Study Evaluating the Use of the PVAC Catheter Technology for Performing Ablation in Patients With Atrial FibrillationRecruitingNo Results AvailableAtrial FibrillationDevice: Radiofrequency Ablation Procedure|Device: Radiofrequency Ablation Procedurehttps://ClinicalTrials.gov/show/NCT01562912
7663676636A Study of MEK162 and AMG 479 in Patients With Selected Solid TumorsCompletedNo Results AvailableKRAS Mutated Colorectal Adenocarcinoma.|Metastatic Pancreatic Adenocarcinoma|BRAF Mutated MelanomaDrug: MEK162 + AMG 479https://ClinicalTrials.gov/show/NCT01562899
7663776637The Rilpivirine Cerebrospinal-fluid (CSF) StudyCompletedHas ResultsHIVDrug: Rilpivirinehttps://ClinicalTrials.gov/show/NCT01562886
7663876638Ruxolitinib in Patients With Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT01562873
7663976639Influence of Pronator Teres Release on Treatment of Median Nerve Compression NeuropathyRecruitingNo Results AvailableMedian Nerve CompressionProcedure: Pronator Teres Release|Procedure: dual compression release|Procedure: dual compression release|Procedure: median nerve release onlyhttps://ClinicalTrials.gov/show/NCT01562860
7664076640Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With NilotinibActive, not recruitingNo Results AvailableChronic Myeloid LeukemiaDrug: Nilotinibhttps://ClinicalTrials.gov/show/NCT01562847
7664176641Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult PatientsCompletedNo Results AvailableGrowth Hormone Disorder|Adult Growth Hormone DeficiencyDrug: somatropin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01562834
7664276642Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial HepatectomyCompletedNo Results AvailableAcquired Bleeding Disorder|CirrhosisDrug: activated recombinant human factor VII|Drug: activated recombinant human factor VII|Drug: placebohttps://ClinicalTrials.gov/show/NCT01562821
7664376643Change in Brain Metabolism and Cognitive Function by AripiprazoleCompletedNo Results AvailableAntipsychotics|Cognition|Brain Metabolism|Dopamine Receptor OccupancyDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT01562808
7664476644Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseCompletedNo Results AvailableModerate to Severe Dry Eye SyndromeDrug: nonsteroid anti-inflammatory drops|Drug: nonsteroid anti-inflammatory drops|Drug: corticosteroids|Drug: artificial tear substitutehttps://ClinicalTrials.gov/show/NCT01562795
7664576645Change of Fructose to Fat in South AsiansActive, not recruitingNo Results AvailableElevated Triglycerides|Diabetes|Cardiovascular Disease|DyslipidemiaOther: Fructose + Glucose Beveragehttps://ClinicalTrials.gov/show/NCT01562782
7664676646Interest of Contact Precautions for Preventing Micro-organisms Acquisition in Patients Hospitalized in Infectious Disease Unit of University-affiliated Hospital in RennesTerminatedNo Results AvailablePatients Hospitalized in Infectious Diseasehttps://ClinicalTrials.gov/show/NCT01562769
7664776647Patient Response to Spinal Manipulation - Pilot StudyCompletedNo Results AvailableLow Back PainOther: HVLA-SMhttps://ClinicalTrials.gov/show/NCT01562756
7664876648A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs SyndromeCompletedHas ResultsIdiopathic Restless Legs SyndromeDrug: SPM 962https://ClinicalTrials.gov/show/NCT01562743
7664976649Myovista iECG for Detecting Ischemic Heart Disease: Comparison With Computed Tomography Coronary AngiographyRecruitingNo Results AvailableCoronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT01562730
7665076650Efficacy and Safety of Ibuprofen in Patients With Ankle InjuriesCompletedNo Results AvailablePainDrug: Ibuprofen|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01562717

* Görseller ve İçerik tekif hakkına sahip olabilir